Quality of death in cancer: no treatment versus late chemotherapy in a nationwide mortality follow-back study
The absence of anticancer treatment was not associated with a poorer QOD in untreated patients. Socioeconomic disparities among younger patients highlight the need for equitable access to cancer care and support for value-based EOL decision-making.
Authors
- Yoshiyuki Kizawa (ORCID: https://orcid.org/0000-0003-2456-5092)
- Yoko Nakazawa (ORCID: https://orcid.org/0000-0003-3658-4514)
- Jun Hamano (ORCID: https://orcid.org/0000-0003-0304-9881)
- Yasuyuki Okumura (ORCID: https://orcid.org/0000-0001-5851-8919)
- Asao Ogawa (ORCID: https://orcid.org/0000-0003-0436-6934)
- Emi Takeuchi (ORCID: https://orcid.org/0000-0003-1632-6876)
- Hiroshi Yamamoto (ORCID: https://orcid.org/0000-0001-8907-3166)
- Risa Yamazaki (ORCID: https://orcid.org/0000-0001-9717-6763)
- Shohei Kawagoe
- Mitsunori Miyashita
- T. Morita
Institutions
- Hamamatsu University (JP)
- University of Tsukuba (JP)
- Chiba University (JP)
- Tohoku University (JP)
- National Cancer Centre Japan (JP)
- Seirei Mikatabara General Hospital (JP)
- U.S. President's Malaria Initiative (US)
- Tokyo Metropolitan Institute of Gerontology (JP)
- National Cancer Center Hospital East (JP)
- Tokyo Metropolitan Geriatric Hospital (JP)
- National Cancer Research Institute (GB)
- Kitasato University (JP)
Publication Details
- Journal
- BMJ Supportive & Palliative Care
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1136/spcare-2025-005832
- Primary Topic
- Palliative Care and End-of-Life Issues
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health, Labour and Welfare